Intravascular Ultrasound-Guided Management of Angiographically Intermediate Non-Culprit Coronary Artery Lesions in Acute Coronary Syndrome

Size: px
Start display at page:

Download "Intravascular Ultrasound-Guided Management of Angiographically Intermediate Non-Culprit Coronary Artery Lesions in Acute Coronary Syndrome"

Transcription

1 Med. J. Cairo Univ., Vol. 85, No. 4, June: , Intravascular Ultrasound-Guided Management of Angiographically Intermediate Non-Culprit Coronary Artery Lesions in Acute Coronary Syndrome FAROUK M. FARES, M.D.; AKRAM M. ABD ELBARY, M.D.; AHMED H. MOWAF, M.D.; MOHAMED A. SHAWKY, M.D. and HELMY H. ELGHAWABY, M.D. The Department of Critical Care Medicine, Faculty of Medicine, Cairo University Abstract Background: The assessment of intermediate coronary lesions using coronary angiography is often challenging. The purpose of this study was to use an intravascular ultrasoundguided strategy to determine the anatomical significance of angiographically intermediate non-culprit coronary lesions to help in their management in the setting of ACS. Methods: We conducted an intravascular ultrasound studies on sixty one angiographically intermediate non-culprit coronary lesions in twenty eight patients with Non ST elevation ACS. Revascularization was recommended when percent area stenosis 70% Results: Minimal and maximal lumen diameters were significantly lower (p<0.001), MLA was significantly lower (p<0.001) and percent area stenosis was significantly higher in revascularization group (p<0.001). MLA & plaque burden are the main predictors for lesion anatomical significance with (p<0.001, OR=0.25, 95% CI= ) and ( p=0.011, OR=2.0, 95% CI= ) respectively. Conclusions: MLA & plaque burden are the main predictors for lesion anatomical significance. Key Words: Intermediate lesions IVUS: Intravascular ultrasound MLA: Minimal lumen area ACS: Acute coronary syndrome. Introduction ACUTE coronary syndromes may frequently arise from lesions with only mild to moderate stenosis since these lesions may be more common than severe obstructive lesions [1-5]. Conventional angiography is the gold standard in clinical practice for diagnosing atherosclerotic compromise of the coronary artery tree. However, coronary angiography has several known limitations, including a lack of correlation between the Correspondence to: Dr. Farouk M. Fares, The Department of Critical Care Medicine, Faculty of Medicine, Cairo University percentage of stenosis and the lesion s physiologic importance and considerable inter-observer variability in classifying the lesion s severity [6-8]. IVUS has been used extensively for assessment of intermediate coronary lesions to demonstrate functional significance (the induction of ischemia) together with FFR and other non-invasive measures [9]. An IVUS-measured minimal luminal area (MLA) of <4.0mm 2 has been used as a marker of severe coronary artery stenosis, which correlates well with the findings of other methods for diagnosing myocardial ischemia, including singlephoton emission computed tomography (SPECT) [10], doppler wire studies [11], and pressure wire measurement [12]. The clinical importance of this criterion has been confirmed by a study showing that deferral of revascularization is safe for patients with an MLA of >4.0mm 2 [13]. Also, IVUS can guide therapeutic strategy in lesions requiring percutaneous coronary intervention (PCI), and assess stent deployment [14]. Aim of work: The use an intravascular ultrasound-guided strategy to determine the anatomical significance of angiographically intermediate non-culprit coronary lesions to help in their management in the setting of ACS. Patients and Methods An observational cross-sectional study was conducted at Critical Care Department, Cairo University between January 2013 and December Inclusion criteria: Twenty eight patients with the diagnosis of unstable angina and non-st- 1335

2 1336 Intravascular Ultrasound-Guided Management of Angiographically Intermediate elevation myocardial infarction had sixty one angiographically-intermediate non-culprit coronary lesions either in culprit or non-culprit vessels. According to the American College of Cardiology and the American Heart Association, intermediate stenosis was defined as having a diameter of 40% and <70%, as measured by quantitative coronary angiography (QCA) [15]. IVUS had been used to further define the severity of these lesions then management either conservatively or by percutaneous coronary intervention (PCI). All patients had clinical evidence of myocardial ischemia in the territory of the culprit vessel including ECG changes, perfusion defects on technetium 99m sestamibi (MIBI) single photon emission computed tomography (SPECT) and regional wall motion abnormalities on echocardiograms. Exclusion criteria: Patients were excluded if they had an ST-elevation acute myocardial infarction, any contraindication to anticoagulation, renal impairment or previous coronary artery bypass grafting (CABG). Diagnostic methods: The diagnostic angiograms were obtained using Digital Imaging and Communications in Medicine (DICOM)-compatible digital systems (Siemens AG model No , Germany & Philips CV20, Netherland). Prior to beginning the IVUS studies, patients were given 10,000 U of unfractionated heparin for systemic anticoagulation. IVUS was performed using conventional 6Fr guiding catheters and a 0.014mm guidewire was positioned distally. IVUS catheters of 40MHz (Atlantis; Boston Scientific Corp., Natick, Massachusetts) were pulled back automatically at a constant speed of 0.5mm/second. The measurements were performed according to the guidelines of the American College of Cardiology for the acquisition, measurement and reporting of IVUS studies [16]. The following parameters were included in the IVUS analyses: Minimal lumen area (MLA), external elastic membrane (EEM) cross sectional area, plaque area, percent area stenosis, remodeling index, minimal and maximal lumen diameters, proximal and distal reference diameter. Plaque burden is calculated as plaque area divided by the EEM cross sectional area. If EEM area increases during atheroma development, the process is termed positive remodeling. If the EEM decreases, the process is termed negative or constrictive remodeling. An index that describes the magnitude and direction of remodeling is expressed as: Lesion EEM CSA/reference EEM CSA. If the lesion EEM area is greater than the reference EEM area, positive remodeling has occurred, and the index will be >1.0. If the lesion EEM area is smaller than the reference EEM area, negative remodeling has occurred, and the index will be <1.0 [17]. Statistical analysis: Pre-coded data was entered on the computer using "Microsoft Office Excel Software" program (2010) for windows. Data was then transferred to the Statistical Package of Social Science Software program, version 21 (SPSS) to be statistically analyzed. Data was summarized using mean, standard deviation, median and inter quartile range for quantitative variables and frequency and percentage for qualitative ones. Comparison between groups was performed using independent sample t-test or one way ANOVA with Tukey s post hoc test for quantitative variables and Chi square or Fisher s exact test for qualitative ones. Pearson correlation coefficients were calculated to get the association between different quantitative variables. Logistic regression analysis was performed to explore the significant predictors of revascularization. p-values less than 0.05 were considered statistically significant, and less than 0.01 were considered highly significant. Results Twenty eight patients presented by NSTEMI ACS with the following demographic & clinical data as in Table (1). Table (1): Demographic and clinical data of study patients. Range Mean ± SD Age (years) ±9.1 Body mass index ±2.9 TIMI risk score ± 1.4 Laboratory results: Hemoglobin (gm%) ± 1.7 Creatinine (mg/dl) ±0.2 Cholesterol (mg/dl) ±30.4 Frequency Percentage (n=28) (%) Gender: Male Female Risk factors: Smoking Diabetes Mellitus Hypertension Dyslipidemia ve Family history History of CAD: Previous MI Previous PCI Clinical diagnosis: Unstable angina NSTEMI

3 Farouk M. Fares, et al Angiographic data: Shown in Table (2) & Fig. (1): Table (2): Number of vessels diseased. Number of patients Percentage Single vessel disease Two vessel disease Multi-vessel disease lesions Visual assessment Significant Intermediate Non-significant lesions=31 lesions=61 lesions=11 7.1% IVUS 60.8% 32.1% Medical treatment Group I=34 Revascularization Group II=27 Fig. (3): Distribution and fate of all lesions. Single vessel disease 55.7% Multi-vessel disease Two vessel disease Fig. (1): Number of vessels diseased. Coronary angiography showed 103 total lesions divided by visual assessment into: Thirty one significant lesions (30.1%) showed more than 70% stenosis. Sixty one intermediate lesions (59.2%) with 40-70% stenosis. Eleven non-significant lesions (10.7%) with less than 40% stenosis. Fifty three (86.8%) of the 61 intermediate lesions were located at the proximal and midportions of the artery. According to the adopted IVUS criteria (percent area stenosis >70%), the lesions were divided into two groups; group I including 34 lesions (55.7%) for deferral of revascularization and group II including 27 lesions (44.3%) for revascularization. 44.3% Group II lesions were more severe, as indicated by a higher percentage of luminal area stenosis (p<0.001) and lower minimal lumen area (p<0.001) detected by IVUS. Also, maximal and minimal lumen diameters were significantly lower in revascularization group than medical treatment group (p<0.001). Mean lesion MLA Mean percent stenosis p< ± ± ± 1.56 p<0.001 Medical treatment Revascularization Fig. (4): Lesion MLA in both groups ± Revascularization Medical treatment Fig. (2): Grouping according to IVUS measures Medical treatment Revascularization Fig. (5): Percent area stenosis in both groups.

4 1338 Intravascular Ultrasound-Guided Management of Angiographically Intermediate Most of the lesions were eccentric and showed negative remodeling [34 lesions (55.7%)] Percentage 44.3 Negative remodelling Positive remodelling Fig. (6): Remodeling of intermediate lesions. Further analysis of IVUS data by Backward stepwise regression model showed that MLA & plaque burden are the main predictors for lesion anatomical significance with (p<0.001, OR=0.25, 95% CI= ) and (p=0.011, OR=2.0, 95% CI= ) respectively. Discussion Assessment of a coronary lesion with intermediate severity continues to be a challenge. It might be tempting to treat all suspect lesions with implantation of a stent. However, there are still procedural complications associated with angioplasty, the inherent risk of restenosis, and late stent thrombosis [18,19]. Although it is preferable to have objective evidence of myocardial ischemia before proceeding with percutaneous coronary revascularization, this is not always feasible or completely reliable. All measures of noninvasive assessment of myocardial ischemia are compared with the presence of a focal stenosis >50% diameter. This cutoff is based on animal studies and human clinical correlations that demonstrate functional significance (the induction of ischemia) with the anatomic presence of a 50% diameter stenosis [9]. An important finding in our study was that most of lesions (49.2%) were located in the proximal segments of the examined arteries. Numerous pathological, angiographic, and imaging studies have shown a proximal predisposition of thin capped fibro-atheroma, acute occlusions, or plaque ruptures [20-25]. This tendency of advanced plaques to develop preferentially in these locations has been explained by the low shear stress conditions generated in areas with tortuosity or many branches. Low shear stress may induce the migration of lipid and monocytes into the vessel wall leading to the progression of the lesion towards a plaque with high risk of rupture [26]. The decision to intervene on a lesion is frequently made in the catheterization laboratory based on the visual estimation of the lesion s severity. Lesions with more than 70% stenosis on visual quantification are usually considered hemodynamically significant and submitted to intervention. However, data from pressure wire evaluation of lesions with less than 70% compromise of luminal diameter have shown that they are also frequently associated with impaired flow reserve and myocardial ischemia [27,28]. Moreover, previous IVUS studies have demonstrated the correlation between a MLA <4.0mm 2 and decreased fractional flow reserve [29], while a MLA 4.0mm 2 was correlated with a preserved fractional flow reserve and favorable outcomes with deferral of invasive intervention [13]. In the present study, 10% of the lesions diagnosed as moderate by conventional angiography had, in fact, severe stenosis by the adopted IVUS criterion (percent area stenosis >70%). The most obvious finding revealed from the analysis of our data is that minimal lumen area (MLA) & plaque burden were the main predictors for lesion significance for revascularization. These results are in agreement with those obtained by Koo et al. [20] which showed that minimal lumen area was the main determinant of functionally significant stenosis. Furthermore, Kang et al. [30] compared quantitative coronary angiography and intravascular ultrasound (IVUS) with stress myocardial singlephoton emission computed tomography (SPECT). Independent determinants for a positive SPECT were in-segment angiographic diameter stenosis & in-segment IVUS-MLA. Conclusion: Our study shows that intravascular ultrasound is a helpful tool in accurately assessing the degree of stenosis in the coronary lesions that appear angiographically intermediate in patients with ACS. Additionally, MLA & plaque burden are the main predictors for lesion anatomical significance. References 1- AMBROSE J.A., TANNENBAUM M.A., ALEXOPOU- LOS D., et al.: Angiographic progression of coronary artery disease and the development of myocardial infarction. J. Am. Coll. Cardiol., 12: 56-62, 1988.

5 Farouk M. Fares, et al LITTLE W.C., CONSTANTINESCU M., APPLEGATE R.J., et al.: Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mildto-moderate coronary artery disease? Circulation, 78: , GIROUD D., LI J.M., URBAN P., et al.: Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am. J. Cardiol., 69: , ALDERMAN E.L., CORLEY S.D., FISHER L.D., et al.: Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). J. Am. Coll. Cardiol., 22: , FALK E., SHAH P.K. and FUSTER V.: Coronary plaque disruption. Circulation, 92: , WHITE C.W., WRIGHT C.B., DOTY D.B., et al.: Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N. Engl. J. Med., 310: , ZIR L.M., MILLER S.W., DINSMORE R.E., et al.: Interobserver variability in coronary angiography. Circulation, 53: , DETRE K.M., WRIGHT E., MURPHY M.L. and TAKA- RO T.: Observer agreement in evaluating coronary angiograms. Circulation, 52: , GOULD K.L., LIPSCOMB K. and HAMILTON G.W.: Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am. J. Cardiol., 33: 87-94, NISHIOKA T., AMANULLAH A.M., LUO H., et al.: Clinical validation of intravascular ultrasound imaging for assessment of coronary stenosis severity: Comparison with stress myocardial perfusion imaging. J. Am. Coll. Cardiol., 33: , ABIZAID A., MINTZ G.S., PICHARD A.D., et al.: Clinical, intravascular ultrasound, and quantitative angiographic determinants of the coronary flow reserve before and aft er percutaneous transluminal coronary angioplasty. Am. J. Cardiol., 82: , TAKAGI A., TSURUMI Y., ISHII Y., et al.: Clinical potential of intravascular ultrasound for physiological assessment of coronary stenosis: Relationship between quantitative ultrasound tomography and pressure-derived fractional flow reserve. Circulation, 100: , ABIZAID A.S., MINTZ G.S., MEHRAN R., et al.: Longterm follow-up after percutaneous transluminal coronary angioplasty was not performed based on intravascular ultrasound findings: Importance of lumen dimensions. Circulation, 100: , MICHAEL C. McDANIEL, PARHAM ESHTEHARDI, FADI J. SAWAYA, et al.: Contemporary Clinical Applications of Coronary Intravascular Ultrasound. J. Am. Coll. Cardiol. Intv., 4: , SMITH S.C. Jr, DOVE J.T., JACOBS A.K., et al.: ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines) Executive summary. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J. Am. Coll. Cardiol., 37: , MINTZ G.S., NISSEN S.E., ANDERSON W.D., et al.: American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J. Am. Coll. Cardiol., 37: , SCHOENHAGEN P., ZIADA K.M., KAPADIA S.R., et al.: Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: An intravascular ultrasound study. Circulation, 101: , STONE G.W., ELLIS S.G., COX D.A., et al.: One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation, 109: , MOSES J.W., LEON M.B., POPMA J.J., et al.: Sirolimuseluting stents versus standard stents in patients with stenosis in a native coronary artery. N. Engl. J. Med., 349: , BON-KWON KOO, HYOUNG-MO YANG, JUN- HYUNG DOH, et al.: Optimal Intravascular Ultrasound Criteria and Their Accuracy for Defining the Functional Significance of Intermediate Coronary Stenoses of Different Locations. JACC: Cardiovascular interventions, Vol. 4, No. 7, : , MARLOS R. FERNANDES, GUILHERME V. SILVA, ADRIANO CAIXETA, et al. Assessing Intermediate Coronary Lesions: Angiographic Prediction of Lesion Severity on Intravascular Ultrasound. Journal of Invasive Cardiology, Volume 19 (10): 412-6, CHERUVU P.K., FINN A.V., GARDNER C., et al.: Frequency and distribution of thincap fibroatheroma and ruptured plaques in human coronary arteries: A pathologic study. J. Am. Coll. Cardiol., 50: 940-9, KUME T., OKURA H., YAMADA R., et al.: Frequency and spatial distribution of thin-cap fibroatheroma assessed by 3-vessel intravascular ultrasound and optical coherence tomography: an ex vivo validation and an initial in vivo feasibility study. Circ. J., 73: , HONG M.K., MINTZ G.S., LEE C.W., et al.: The site of plaque rupture in native coronary arteries: A three-vessel intravascular ultrasound analysis. J. Am. Coll. Cardiol., 46: 261-5, ANDO H., AMANO T., MATSUBARA T., et al.: Comparison of tissue characteristics between acute coronary syndrome and stable angina pectoris. An integrated backscatter intravascular ultrasound analysis of culprit and nonculprit lesions. Circ. J., 75: , CUNNINGHAM K.S. and GOTLIEB A.I.: The role of shear stress in the pathogenesis of atherosclerosis. Lab. Invest, 85: 9-23, WEIDEMANN F., JUNG P., HOYER C., et al.: Assessment of the contractile reserve in patients with intermediate coronary lesions: A strain rate imaging study validated by invasive myoc ardia l fra ctional flow reserve. Eur. Heart J., 28: , 2007.

6 1340 Intravascular Ultrasound-Guided Management of Angiographically Intermediate 28- HACKER M., RIEBER J., SCHMID R., et al.: Comparison of Tc-99m sestamibi SPECT with fractional flow reserve in patients with intermediate coronary artery stenoses. J. Nucl. Cardiol., 12: , BRIGUORI C., ANZUINI A., AIROLDI F., et al.: Intravascular ultrasound criteria for the assessment of the functional significance of intermediate coronary artery stenoses and comparison with fractional flow reserve. Am. J. Cardiol., 87: , KANG S.J., CHO Y.R., PARK G.M., et al.: Predictors for functionally significant in-stent restenosis: An integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging. JCMG. Nov. 6 (11): , 2013.

New Insight about FFR and IVUS MLA

New Insight about FFR and IVUS MLA New Insight about FFR and IVUS MLA Can IVUS MLA Predict FFR

More information

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,

More information

Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013

Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013 Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013 Disclosures Consultant- St Jude Medical Boston Scientific Speaker- Volcano Corporation Heart

More information

Declaration of conflict of interest. Nothing to disclose

Declaration of conflict of interest. Nothing to disclose Declaration of conflict of interest Nothing to disclose Hong-Seok Lim, Seung-Jea Tahk, Hyoung-Mo Yang, Jin-Woo Kim, Kyoung- Woo Seo, Byoung-Joo Choi, So-Yeon Choi, Myeong-Ho Yoon, Gyo-Seung Hwang, Joon-Han

More information

Anatomy is Destiny, But Physiology is Here Today

Anatomy is Destiny, But Physiology is Here Today Published on Journal of Invasive Cardiology (http://www.invasivecardiology.com) September, 2010 [1] Anatomy is Destiny, But Physiology is Here Today Thu, 9/9/10-10:54am 0 Comments Section: Commentary Issue

More information

Between Coronary Angiography and Fractional Flow Reserve

Between Coronary Angiography and Fractional Flow Reserve Visual-Functional Mismatch Between Coronary Angiography and Fractional Flow Reserve Seung-Jung Park, MD., PhD. University of Ulsan, College of Medicine Asan Medical Center, Seoul, Korea Visual - Functional

More information

Gary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function

Gary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function Gary S. Mintz,, MD IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function Important IVUS Observations: Remodeling Originally used (first by Glagov) ) to explain atherosclerosis

More information

The Site of Plaque Rupture in Native Coronary Arteries

The Site of Plaque Rupture in Native Coronary Arteries Journal of the American College of Cardiology Vol. 46, No. 2, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.03.067

More information

Plaque Shift vs. Carina Shift Prevalence and Implication

Plaque Shift vs. Carina Shift Prevalence and Implication TCTAP 2013 Fellowship Course Left Main and Bifurcation PCI: Bifurcation PCI Plaque Shift vs. Carina Shift Prevalence and Implication Soo-Jin Kang, MD., PhD. Department of Cardiology, University of Ulsan

More information

FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study

FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study Journal of the American College of Cardiology Vol. 61, No. 9, 2013 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.12.012

More information

IVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea

IVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea IVUS Analysis Myeong-Ki Hong, MD, PhD Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Intimal disease (plaque) is dense and will appear white Media is made of

More information

So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of Medicine, Korea

So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of Medicine, Korea So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of Medicine, Korea Anatomical vs Functional Significance? Coronary Angiogram Treadmill Test Tc-99m-MIBI SPECT MDCT Coronary Angiogram

More information

Intravascular ultrasound-based analysis of factors affecting minimum lumen area in coronary artery intermediate lesions

Intravascular ultrasound-based analysis of factors affecting minimum lumen area in coronary artery intermediate lesions Journal of Geriatric Cardiology (2016) 13: 169 174 2016 JGC All rights reserved; www.jgc301.com Research Article Open Access Intravascular ultrasound-based analysis of factors affecting minimum lumen area

More information

Cardiovascular Research Foundation and Columbia University Medical Center, New York.

Cardiovascular Research Foundation and Columbia University Medical Center, New York. Virtual Histology Intravascular Ultrasound Analysis of Non-culprit Attenuated Plaques Detected by Grayscale Intravascular Ultrasound in Patients with Acute Coronary Syndromes Xiaofan Wu, Akiko Maehara,

More information

Integrated Use of IVUS and FFR for LM Stenting

Integrated Use of IVUS and FFR for LM Stenting Integrated Use of IVUS and FFR for LM Stenting Gary S. Mintz, MD Cardiovascular Research Foundation Four studies have highlighted the inaccuracy of angiography in the assessment of LMCA disease Fisher

More information

Side Branch Occlusion

Side Branch Occlusion Side Branch Occlusion Mechanism, Outcome, and How to avoid it From COBIS II Registry Hyeon-Cheol Gwon Cardiac&Vascular Center, Samsung Medical Center Sungkyunkwan University School of Medicine SB occlusion

More information

Upgrade of Recommendation

Upgrade of Recommendation Challenges in LM PCI Decision-making process for stenting Young-Hak Kim, MD, PhD, Heart Institute, University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea Upgrade of Recommendation for

More information

FFR-guided Jailed Side Branch Intervention

FFR-guided Jailed Side Branch Intervention FFR-guided Jailed Side Branch Intervention - Pressure wire in Bifurcation lesions - Bon-Kwon Koo, MD, PhD Seoul National University Hospital, Seoul, Korea Bifurcation Lesions Bifurcation Lesions Still

More information

Validation of Minimal Luminal Area Measured by Intravascular Ultrasound for Assessment of Functionally Significant Coronary Stenosis

Validation of Minimal Luminal Area Measured by Intravascular Ultrasound for Assessment of Functionally Significant Coronary Stenosis JACC: CARDIOVASCULAR INTERVENTIONS VOL. 4, NO. 6, 2011 2011 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2011.02.013 Validation

More information

FFR and intravascular imaging, which of which?

FFR and intravascular imaging, which of which? FFR and intravascular imaging, which of which? Ayman Khairy MD, PhD, FESC Associate professor of Cardiovascular Medicine Vice Director of Assiut University Hospitals Assiut, Egypt Diagnostic assessment

More information

PCI for Left Anterior Descending Artery Ostial Stenosis

PCI for Left Anterior Descending Artery Ostial Stenosis PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary

More information

FFR Incorporating & Expanding it s use in Clinical Practice

FFR Incorporating & Expanding it s use in Clinical Practice FFR Incorporating & Expanding it s use in Clinical Practice Suleiman Kharabsheh, MD Consultant Invasive Cardiology Assistant professor, Alfaisal Univ. KFHI - KFSHRC Concept of FFR Maximum flow down a vessel

More information

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center Fractional Flow Reserve: Basics, FAME 1, FAME 2 William F. Fearon, MD Associate Professor Stanford University Medical Center Conflict of Interest Advisory Board for HeartFlow Research grant from St. Jude

More information

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators

More information

CASE from South Korea

CASE from South Korea CASE from South Korea Bon-Kwon Koo, MD, PhD, Seoul, Korea Outpatient clinic of a non-interventional cardiologist F/56 Chief complaint: Angina with recent aggravation, CCS II~III Brief history: # Stroke

More information

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively

More information

Diabetes and Occult Coronary Artery Disease

Diabetes and Occult Coronary Artery Disease Diabetes and Occult Coronary Artery Disease Mun K. Hong, MD, FACC, FSCAI Director, Cardiac Catheterization Laboratory & Interventional Cardiology St. Luke s-roosevelt Hospital Center New York, New York

More information

Patient referral for elective coronary angiography: challenging the current strategy

Patient referral for elective coronary angiography: challenging the current strategy Patient referral for elective coronary angiography: challenging the current strategy M. Santos, A. Ferreira, A. P. Sousa, J. Brito, R. Calé, L. Raposo, P. Gonçalves, R. Teles, M. Almeida, M. Mendes Cardiology

More information

IVUS-Guided d Provisional i Stenting: Plaque or Carina Shift. Soo-Jin Kang, MD., PhD.

IVUS-Guided d Provisional i Stenting: Plaque or Carina Shift. Soo-Jin Kang, MD., PhD. Left Main and Bifurcation Summit IVUS-Guided d Provisional i Stenting: ti Plaque or Carina Shift Soo-Jin Kang, MD., PhD. Department of Cardiology, University of Ulsan College of Medicine Asan Medical Center,

More information

Can IVUS Define Plaque Features that Impact Patient Care?

Can IVUS Define Plaque Features that Impact Patient Care? Can IVUS Define Plaque Features that Impact Patient Care? A Pichard L Satler, K Kent, R Waksman, W Suddath, N Bernardo, N Weissman, M Angelo, D Harrington, J Lindsay, J Panza. Washington Hospital Center

More information

Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE

Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE Conflict of interest None to declare While IVUS is the most used intravascular

More information

Title for Paragraph Format Slide

Title for Paragraph Format Slide Title for Paragraph Format Slide Presentation Title: Month Date, Year Atherosclerosis A Spectrum of Disease: February 12, 2015 Richard Cameron Padgett, MD Executive Medical Director, OHVI Pt RB Age 38

More information

2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center

2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center 2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium Does Lt Late Cth Catch up Exist Eiti in DES? : Quantitative Coronary Angiography Analysis Kyung Woo Park, MD Cardiovascular

More information

Prognostic Value of Gated Myocardial Perfusion SPECT

Prognostic Value of Gated Myocardial Perfusion SPECT Current Use of IVUS & FFR George D. Dangas, MD, PhD, FACC, FSCAI Professor of Medicine Mount Sinai School of Medicine Prognostic Value of Gated Myocardial Perfusion SPECT 0.6% / year, Cardiac Death and

More information

Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion

Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion Assessment of Coronary Plaque Rupture and Erosion Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion Yukio Ozaki, MD, PhD, FACC, FESC Cardiology Dept., Fujita Health Univ. Toyoake,

More information

THE COMPLEX RELATION BETWEEN VULNERABILITY AND ISCHEMIA a paradigm shift

THE COMPLEX RELATION BETWEEN VULNERABILITY AND ISCHEMIA a paradigm shift THE COMPLEX RELATION BETWEEN VULNERABILITY AND ISCHEMIA a paradigm shift Angioplasty Summit TCT ASIA Seoul, Korea, april 23rd, 2008 Nico H. J. Pijls, MD, PhD Catharina Hospital, Eindhoven, The Netherlands

More information

Fractional Flow Reserve. A physiological approach to guide complex interventions

Fractional Flow Reserve. A physiological approach to guide complex interventions Fractional Flow Reserve A physiological approach to guide complex interventions What is FFR? Fractional Flow Reserve (FFR) is a lesion specific, physiological index determining the hemodynamic severity

More information

Premier Health Plan considers Intravascular Ultrasound (IVUS) for Coronary Vessels medically necessary for the following indications:

Premier Health Plan considers Intravascular Ultrasound (IVUS) for Coronary Vessels medically necessary for the following indications: Premier Health Plan POLICY AND PROCEDURE MANUAL MP.091.PH - Intravascular Ultrasound for Coronary Vessels This policy applies to the following lines of business: Premier Commercial Premier Employee Premier

More information

Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging

Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging Gary S. Mintz,, MD Cardiovascular Research Foundation New York, NY Today, in reality, almost everything

More information

Noninvasive Fractional Flow Reserve from Coronary CT Angiography

Noninvasive Fractional Flow Reserve from Coronary CT Angiography 2016 KSC Annual Spring Scientific Conference Noninvasive Fractional Flow Reserve from Coronary CT Angiography Bon-Kwon Koo, MD, PhD, Seoul, Korea Why the hemodynamics for coronary artery disease? Twinlifemarketing.com.au

More information

Can We Safely Defer PCI. Yes, already proven

Can We Safely Defer PCI. Yes, already proven Can We Safely Defer PCI Just Based on FFR>0.80? Yes, already proven Seung-Jung Park, MD., PhD. Professor of Medicine, University of Ulsan, College of Medicine Heart Institute, Asan Medical Center, Seoul,

More information

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? Keun-Ho Park, Myung Ho Jeong, Min Goo Lee, Jum Suk Ko,

More information

Quick guide. Core. precision guided therapy system

Quick guide. Core. precision guided therapy system Quick guide Core precision guided therapy system The Philips Volcano imaging system should only be operated by trained personnel. The following information is presented for your convenience and is not

More information

Diagnostic Accuracy of Fractional Flow Reserve from Anatomic Computed TOmographic Angiography: The DeFACTO Study

Diagnostic Accuracy of Fractional Flow Reserve from Anatomic Computed TOmographic Angiography: The DeFACTO Study Diagnostic Accuracy of Fractional Flow Reserve from Anatomic Computed TOmographic Angiography: The DeFACTO Study James K. Min 1 ; Jonathon Leipsic 2 ; Michael J. Pencina 3 ; Daniel S. Berman 1 ; Bon-Kwon

More information

DESolve NX Trial Clinical and Imaging Results

DESolve NX Trial Clinical and Imaging Results DESolve NX Trial Clinical and Imaging Results Alexandre Abizaid, MD, PhD, Instituto Dante Pazzanese, Sao Paulo, Brazil On behalf of the DESolve Nx Trial Investigators Please refer to the TCT2014 App or

More information

대한심장학회춘계학술대회 Satellite Symposium

대한심장학회춘계학술대회 Satellite Symposium 대한심장학회춘계학술대회 Satellite Symposium Coronary Plaque Regression and Compositional Changes by Lipid-Lowering Therapy: IVUS Substudy in Livalo (Pitavastatin) in Acute Myocardial Infarction Study (LAMIS) Livalo

More information

Assessment of plaque morphology by OCT in patients with ACS

Assessment of plaque morphology by OCT in patients with ACS Assessment of plaque morphology by OCT in patients with ACS Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Unstable plaque Intima Lipid core Plaque rupture and coronary events

More information

COURAGE to Leave Diseased Arteries Alone

COURAGE to Leave Diseased Arteries Alone COURAGE to Leave Diseased Arteries Alone Spencer King MD MACC, FSCAI St. Joseph s s Heart and Vascular Institute Professor of Medicine Emeritus Emory Univ. Atlanta, USA Conflict: I am an Interventionalist

More information

Angiographic long-term results after implantation of the paclitaxel-eluting coronary stent coroflex please : Data under real-world conditions

Angiographic long-term results after implantation of the paclitaxel-eluting coronary stent coroflex please : Data under real-world conditions 244 U. Gerk, B. Leithäuser, U. Schäfer, F. Jung, J.-W. Park Applied Cardiopulmonary Pathophysiology 14: 244-249, 2010 Angiographic long-term results after implantation of the paclitaxel-eluting coronary

More information

Important LM bifurcation studies update

Important LM bifurcation studies update 8 th European Bifurcation Club 12-13 October 2012 - Barcelona Important LM bifurcation studies update I Sheiban E-mail: isheiban@yahoo.com Unprotected LM Percutaneous Revascularization What is important

More information

FFR in Left Main Disease

FFR in Left Main Disease FFR in Left Main Disease William F. Fearon, MD Associate Professor of Medicine Director, Interventional Cardiology Stanford University Medical Center Why FFR instead of IVUS? Physiologic versus anatomic

More information

A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience

A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience Juan F. Granada, MD Medical Director, Skirball Center for Cardiovascular Research The Cardiovascular

More information

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Gjin Ndrepepa, Tomohisa Tada, Massimiliano Fusaro, Lamin King, Martin Hadamitzky,

More information

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers EAE Teaching Course Magnetic Resonance Imaging Competitive or Complementary? Sofia, Bulgaria, 5-7 April 2012 F.E. Rademakers Complementary? Of Course N Engl J Med 2012;366:54-63 Clinical relevance Treatment

More information

FFR and IVUS Guided DES Implantation in Long Diffuse Lesions

FFR and IVUS Guided DES Implantation in Long Diffuse Lesions FFR and IVUS Guided DES Implantation in Long Diffuse Lesions Can We Reach Optimal DES Expansion With Conventional Stent Delivery System in Long Diffuse Lesion? Seung-Jea Tahk, MD., PhD. Ajou University

More information

Σεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική

Σεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική ΕΛΛΗΝΙΚΗΚΑΡΔΙΟΛΟΓΙΚΗΕΤΑΙΡΕΙΑ Σεμινάριο Ομάδων Εργασίας 2011 Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική GUIDELINES ON MYOCARDIAL

More information

The MAIN-COMPARE Study

The MAIN-COMPARE Study Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

JACC: CARDIOVASCULAR INTERVENTIONS VOL. 4, NO. 7, PUBLISHED BY ELSEVIER INC. DOI: /j.jcin

JACC: CARDIOVASCULAR INTERVENTIONS VOL. 4, NO. 7, PUBLISHED BY ELSEVIER INC. DOI: /j.jcin JACC: CARDIOVASCULAR INTERVENTIONS VOL. 4, NO. 7, 2011 2011 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2011.03.013 Optimal Intravascular

More information

Should we be using fractional flow reserve more routinely to select stable coronary patients for percutaneous coronary intervention?

Should we be using fractional flow reserve more routinely to select stable coronary patients for percutaneous coronary intervention? REVIEW C URRENT OPINION Should we be using fractional flow reserve more routinely to select stable coronary patients for percutaneous coronary intervention? Seung-Jung Park and Jung-Min Ahn Purpose of

More information

Left Main Intervention: Where are we in 2015?

Left Main Intervention: Where are we in 2015? Left Main Intervention: Where are we in 2015? David A. Cox, MD FSCAI Director, Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown, PA Fall Fellows Course Laa

More information

Three-vessel fractional flow reserve measurement for predicting clinical prognosis in patients with coronary artery disease

Three-vessel fractional flow reserve measurement for predicting clinical prognosis in patients with coronary artery disease Editorial Three-vessel fractional flow reserve measurement for predicting clinical prognosis in patients with coronary artery disease Takashi Kubo, Hiroki Emori, Yosuke Katayama, Kosei Terada Department

More information

Fractional Flow Reserve and instantaneous wave -free Ratio. Λάμπρος Κ. Μόσιαλος Επεμβατικός Καρδιολόγος ΓΝ Παπαγεωργίου

Fractional Flow Reserve and instantaneous wave -free Ratio. Λάμπρος Κ. Μόσιαλος Επεμβατικός Καρδιολόγος ΓΝ Παπαγεωργίου Fractional Flow Reserve and instantaneous wave -free Ratio Λάμπρος Κ. Μόσιαλος Επεμβατικός Καρδιολόγος ΓΝ Παπαγεωργίου DISCLOSURES There are no financial conflicts of interest relevant to this presentation

More information

Jose Mª de la Torre Hernandez, MD, PhD, FESC. Cardiologia Valdecilla Hospital Universitario Marques de Valdecilla Santander. SPAIN

Jose Mª de la Torre Hernandez, MD, PhD, FESC. Cardiologia Valdecilla Hospital Universitario Marques de Valdecilla Santander. SPAIN Validation and application of IVUS-MLA in LMCA disease Jose Mª de la Torre Hernandez, MD, PhD, FESC Interventional Cardiology Dpt Cardiologia Valdecilla Hospital Universitario Marques de Valdecilla Santander.

More information

Journal of the American College of Cardiology Vol. 46, No. 5, by the American College of Cardiology Foundation ISSN /05/$30.

Journal of the American College of Cardiology Vol. 46, No. 5, by the American College of Cardiology Foundation ISSN /05/$30. Journal of the American College of Cardiology Vol. 46, No. 5, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.06.009

More information

Unprotected LM intervention

Unprotected LM intervention Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline

More information

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Percutaneous Coronary Interventions Without On-site Cardiac Surgery Percutaneous Coronary Interventions Without On-site Cardiac Surgery Hassan Al Zammar, MD,FESC Consultant & Interventional Cardiologist Head of Cardiology Department European Gaza Hospital Palestine European

More information

Intervention: How and to which extent is technology helping us?

Intervention: How and to which extent is technology helping us? Cardiological Society of India Congress 12th February 2016 Chennai, India Intervention: How and to which extent is technology helping us? SIMONE BISCAGLIA MD CARDIOVASCULAR INSTITUTE, FERRARA, ITALY Introduction

More information

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively

More information

Benefit of Performing PCI Based on FFR

Benefit of Performing PCI Based on FFR Benefit of Performing PCI Based on FFR William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center Benefit of FFR-Guided PCI FFR-Guided PCI vs. Angiography-Guided

More information

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang

More information

Fractional Flow Reserve: Review of the latest data

Fractional Flow Reserve: Review of the latest data Fractional Flow Reserve: Review of the latest data Michalis Hamilos, MD, PhD, FESC University Hospital of Heraklion Fractional Flow Reserve (FFR) Coronary angiography does not always tell the truth Most

More information

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

PCIs on Intermediate Lesions NCDR Cath-PCI Registry Practical Application Of Coronary Physiology in The Cath Lab Talal T Attar, MD, MBA, FACC PCIs on Intermediate Lesions NCDR Cath-PCI Registry Fraction of stenoses 50-70% treated with PCI without further

More information

INSIDE INFORMATION YOU CAN T IGNORE

INSIDE INFORMATION YOU CAN T IGNORE INSIDE INFORMATION YOU CAN T IGNORE Volcano, the Volcano logo and SyncVision are registered trademarks of Volcano Corporation. All other trademarks set-forth are properties of their respective owners.

More information

IVUS Virtual Histology. Listening through Walls D. Geoffrey Vince, PhD The Cleveland Clinic Foundation

IVUS Virtual Histology. Listening through Walls D. Geoffrey Vince, PhD The Cleveland Clinic Foundation IVUS Virtual Histology Listening through Walls D. Geoffrey Vince, PhD Disclosure VH is licenced to Volcano Therapeutics Grant funding from Pfizer, Inc. Grant funding from Boston-Scientific Most Myocardial

More information

Invasive Versus Noninvasive Evaluation of Coronary Artery Disease

Invasive Versus Noninvasive Evaluation of Coronary Artery Disease JACC: CARDIOVASCULAR IMAGING VOL. 1, NO. 2, 2008 2008 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/08/$34.00 PUBLISHED BY ELSEVIER INC. DOI:10.1016/j.jcmg.2007.12.003 Invasive Versus

More information

Intravascular Ultrasound

Intravascular Ultrasound May 2008 Beth Israel Deaconess Medical Center Harvard Medical School Intravascular Ultrasound Matthew Altman, HMS III Gillian Lieberman, MD BIDMC Department of Radiology Presentation Overview 1. Patient

More information

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference

More information

Integrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes. Gary S. Mintz, MD Cardiovascular Research Foundation

Integrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes. Gary S. Mintz, MD Cardiovascular Research Foundation Integrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes Gary S. Mintz, MD Cardiovascular Research Foundation COURAGE Nuclear Substudy (n=314) Death/MI according the residual ischemia (SPECT)

More information

Coronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital

Coronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital Coronary Artery Imaging Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital Larger array : cover scan area Detector size : spatial resolution Rotation speed : scan time Retrospective

More information

Lessons learned From The National PCI Registry

Lessons learned From The National PCI Registry Lessons learned From The National PCI Registry w a v e On Behalf of The Publication Committee of the National PCI Registry Objectives & Anticipated Achievements To determine the epidemiology of patients

More information

PCI for In-Stent Restenosis. CardioVascular Research Foundation

PCI for In-Stent Restenosis. CardioVascular Research Foundation PCI for In-Stent Restenosis ISR of BMS Patterns of In-Stent Restenosis Pattern I : Focal Type IA: Articulation / Gap Type IB: Marginal Type IC: Focal body Type ID: Multifocal Pattern II,III,IV : Diffuse

More information

Clinical Investigations

Clinical Investigations Clinical Investigations Clinical Outcomes for Single Stent and Multiple Stents in Contemporary Practice Qiao Shu Bin, MD; Liu Sheng Wen, MD; Xu Bo, BS; Chen Jue, MD; Liu Hai Bo, MD; Yang Yue Jin, MD; Chen

More information

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Indian TUXEDO Trial In Medically Treated Diabetics Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Executive Director and Dean Escorts Heart Institute & Medical Research Center and Fortis Hospitals, New Delhi

More information

Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection

Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Greyscale IVUS studies have shown Plaque ruptures do not occur randomly

More information

LM stenting - Cypher

LM stenting - Cypher LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with

More information

Sirolimus-Eluting Stents for Treatment of In-Stent Restenosis

Sirolimus-Eluting Stents for Treatment of In-Stent Restenosis Clinical Investigation Alfonso Medina, MD José Suárez de Lezo, MD Manuel Pan, MD Antonio Delgado, MD José Segura, MD Djordje Pavlovic, MD Francisco Melián, MD Miguel Romero, MD Federico Segura, MD Enrique

More information

MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION

MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION C. Graidis, D. Dimitriadis, A. Ntatsios, V. Karasavvides Euromedica Kyanous Stavros, Thessaloniki.

More information

Atypical pain and normal exercise test

Atypical pain and normal exercise test Atypical pain and normal exercise test F. Mut, M. Beretta Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Clinical history 67-year old male with several coronary risk factors. Atypical

More information

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators Heart Vascular Stroke Institute, Samsung Medical Center, Seoul, Republic of

More information

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France PCI for Left Main Coronary Artery Stenosis Jean Fajadet Clinique Pasteur, Toulouse, France Athens, October 19, 2018 Left Main Coronary Artery Disease Significant unprotected left main coronary artery disease

More information

Three-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G.

Three-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G. Three-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G. Ellis MD Dean J. Kereiakes MD and Gregg W. Stone MD for the ABSORB

More information

What do the guidelines say?

What do the guidelines say? Percutaneous coronary intervention in 3-vessel disease and main stem What do the guidelines say? Nothing to disclose Dariusz Dudek Institute of Cardiology, Jagiellonian University Krakow, Poland The European

More information

Abstract Background: Methods: Results: Conclusions:

Abstract Background: Methods: Results: Conclusions: Two-Year Clinical and Angiographic Outcomes of Overlapping Sirolimusversus Paclitaxel- Eluting Stents in the Treatment of Diffuse Long Coronary Lesions Kang-Yin Chen 1,2, Seung-Woon Rha 1, Yong-Jian Li

More information

Post PCI functional testing and imaging: case based lessons from FFR React

Post PCI functional testing and imaging: case based lessons from FFR React Post PCI functional testing and imaging: case based lessons from FFR React Joost Daemen, MD, PhD, FESC Optics in Cardiology 2018 April 21st, 2018 10.15 10.30h Disclosure Statement of Financial Interest

More information

Left Main PCI. Integrated Use of IVUS and FFR. Seung-Jung Park, MD, PhD

Left Main PCI. Integrated Use of IVUS and FFR. Seung-Jung Park, MD, PhD Left Main PCI Integrated Use of IVUS and FFR Seung-Jung Park, MD, PhD Professor of Medicine, University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea Efficacy of Left

More information

Clinical case in perspective. Cases from Poland

Clinical case in perspective. Cases from Poland Clinical case in perspective Cases from Poland Assoc. Prof. Jacek Legutko, MD, PhD President-Elect of the Association for Percutaneous Cardiovascular Interventions of the Polish Cardiac Society Institute

More information

Original Article. Korean Circulation Journal

Original Article. Korean Circulation Journal Original Article Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Clinical Outcomes in Patients with Intermediate Coronary Stenoses: MINIATURE Investigators (Korea MultIceNter TrIal

More information

Clinical Trial Synopsis TL-OPI-516, NCT#

Clinical Trial Synopsis TL-OPI-516, NCT# Clinical Trial Synopsis, NCT#00225277 Title of Study: A Double-Blind, Randomized, Comparator-Controlled Study in Subjects With Type 2 Diabetes Mellitus Comparing the Effects of Pioglitazone HCl Versus

More information

The Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6

The Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6 The Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6 n&list_uids=17433949 64-Multislice Detector Computed Tomography Coronary Angiography as Potential Alternative

More information

PROMUS Element Experience In AMC

PROMUS Element Experience In AMC Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical

More information